Summary
Biogen Idec announced a significant restructuring plan on October 28, 2010, as part of a "framework for growth through increased focus and efficiency" initiated under its new CEO, George A. Scangos. This strategic overhaul involves consolidating facilities, a workforce reduction of approximately 13%, and the termination of 11 research and development programs. The company estimates total restructuring costs to be approximately $164 million, with $159 million expected to result in future cash expenditures. These actions are intended to streamline operations and reallocate resources for future growth and are expected to be substantially completed by the end of 2011. In addition to the restructuring, Biogen Idec also announced a key executive appointment: Robert E. Gagnon has been named Chief Accounting Officer, Vice President, and Controller, effective November 3, 2010. This filing also includes a press release dated November 3, 2010, detailing these events, and highlights the company's forward-looking statements, cautioning investors about potential risks and uncertainties affecting future results, including dependence on key products like AVONEX, RITUXAN, and TYSABRI.
Key Highlights
- 1Biogen Idec is implementing a significant restructuring plan to improve focus and efficiency, under the direction of new CEO George A. Scangos.
- 2The restructuring includes closing a San Diego facility, consolidating operations in Massachusetts, and reducing the workforce by approximately 13%.
- 3Eleven research and development programs will be terminated as part of this strategic realignment.
- 4Total estimated restructuring costs are $164 million, with $159 million anticipated to involve future cash outlays.
- 5These restructuring actions are expected to be substantially completed by the end of 2011.
- 6Robert E. Gagnon has been appointed as the new Chief Accounting Officer, Vice President, and Controller, effective November 3, 2010.
- 7The company released a press release on November 3, 2010, detailing these operational changes and strategic direction.